An official website of the United States government
Hazardous Drugs
June 2007
NIOSH Docket Number 105
A public meeting was held on August 28, 2007, in Washington, DC, to discuss and obtain comments on the draft document, “NIOSH Hazardous Drugs List Update.”
Related Docket
Pre-meeting Information
Notice of request for public to submit comments and attend public meeting; 72 FR 33507; 6/18/07 [PDF – 1,290 KB]
List of new FDA drugs and warnings fitting NIOSH criteria for hazardous drugs; 2006 [PDF – 2,480 KB]
NIOSH Alert, “Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings,” DHHS (NIOSH) Publication No. 2004-105 [PDF – 15,910 KB]
List of new FDA drugs and warnings not fitting NIOSH criteria for hazardous drugs, 2006 [PDF – 3,670 KB]
Meeting Information
Presentation by Reed/Connor (NIOSH) at the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07 [PDF – 2,620 KB]
List of attendees – 8/27/07 [PDF – 44 KB]
Post-Meeting Information
Transcript of the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07; Part 1 [PDF – 22,780 KB]
Transcript of the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07; Part 2 [PDF – 20,830 KB]
Submission to the docket from private person – 6/14/07 [PDF – 279 KB]
Submission to the docket from private person – 6/19/07 [PDF – 17 KB]
Submission to the docket from private person – 6/19/07 [PDF – 23 KB]
Submission to the docket from private person – 6/19/07 [PDF – 295 KB]
Submission to the docket from Thies (St. Luke’s Hospital) – 6/22/07 [PDF – 205 KB]
Submission to the docket from Olson (GlaxoSmithKline) – 8/1/07 [PDF – 196 KB]
Submission to the docket from Fabbro (BC Cancer Agency) – 8/24/07 [PDF – 535 KB]
Submission to the docket from Werner (The National Home Infusion Association) – 8/27/07 [PDF – 675 KB]
Submission to the docket from Schmidt (Western Missouri Mental Health Center) – 8/28/07 [PDF – 1,490 KB]
Submission to the docket from private person – 9/6/07 [PDF – 4,360 KB]
Submission to the docket from private person – 9/8/07 [PDF – 177 KB]
Submission to the docket from Swyres (Barnes-Jewish Hospital) – 9/10/07 [PDF – 2,690 KB]
Submission to the docket from private person – 9/11/07 [PDF – 151 KB]
Submission to the docket from private person – 9/12/07 [PDF – 20 KB]
Submission to the docket from Suter (Novartis Pharma AG) – 9/17/07 [PDF – 984 KB]
Submission to the docket from Wylie (Wyeth) – 9/18/07 [PDF – 1,580 KB]
Submission to the docket from Murano (Genentech, Inc) – 9/18/07 [PDF – 9,420 KB]
Submission to the docket from Oliver (AstraZeneca) – 9/19/07 [PDF – 5,090 KB]
Submission to the docket from Hung (Mayo Clinic) – 9/19/07 [PDF – 12,620 KB]
Submission to the docket from Reilly/Coffey (American Society of Health-System Pharmacists) – 9/20/07 [PDF – 4,760 KB]
Submission to the docket from Collura (Clarian Health) – 9/20/07 [PDF – 1,690 KB]
Submission to the docket from Roman (Boehringer Ingelheim Pharmaceuticals, Inc) – 9/20/07 [PDF – 6,420 KB]
Submission to the docket from Roman (Ben Venue Laboratories) – 9/20/07 [PDF – 216 KB]
Submission to the docket from Schwartz (Pfizer Inc) – 9/20/07 [PDF – 3,090 KB]
Submission to the docket from Sigler (Kaiser Permanente) – 9/20/07 [PDF – 153 KB]
Submission to the docket from Treanor (BioPharma EHS Forum) – 9/20/07 [PDF – 2,730 KB]
Submission to the docket from White (Pharmaceutical Research and Manufacturers of America) – 9/20/07 [PDF – 4,730 KB]
Submission to the docket from Bough/Gans (American Pharmacists Association) – 9/20/07 [PDF – 2,870 KB]
Submission to the docket from Stewart (Kaiser Permanente) – 9/21/07 [PDF – 186 KB]
Submission to the docket from Cadsap (Tercica) – 9/26/07 [PDF – 2,100 KB]
Submission to the docket from McHugh (Gilead Sciences, Inc) – 9/26/07 [PDF – 29,120 KB]
Submission to the docket from Olson (GlaxoSmithKline) – 9/20/07 [PDF – 2,340 KB]
Submission to the docket from McGrath (Bristol-Myers Squibb Company) – 9/28/07 [PDF – 4,830 KB]
Submission to the docket from Olson (GlaxoSmithKline) – 12/12/07 [PDF – 420 KB]
Submission to the docket from Cormack (Sucampo Pharmaceuticals) – 1/22/08 [PDF – 1,960 KB]